Showing 2 of 2 recruiting trials for “GM2 gangliosidosis”
A Study to Evaluate the Safety and Efficacy of Nizubaglustat (AZ-3102) in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease
RecruitingNCT05007990 ↗
Caregiving Networks Across Disease Context and the Life Course
👨⚕️ Laura M Koehly, Ph.D., National Human Genome Research Institute (NHGRI)📍 1 site📅 Started Sep 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →